Stock Fundamentals

Company Information

Company Name
Celcuity LLC
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US15102K1007
CIK: 0001603454
CUSIP: 15102K100
Currency: USD
Full Time Employees: 155
Phone: (763) 392-0123
Fiscal Year End: December
IPO Date: Sep 20, 2017
Description:

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.

Address:

2800 Campus Drive, Minneapolis, MN, United States, 55441

Directors & Officers

Name Title Year Born
Mr. Brian F. Sullivan Co-Founder, Chairman & CEO 1962
Dr. Lance G. Laing Ph.D. Co-Founder, Chief Science Officer, VP, Secretary & Director 1962
Ms. Vicky Hahne CPA Chief Financial Officer 1966
Ms. Jodi Sievers Head of Investor Relations & Corporate Communications NA
Mr. Brent Eilefson General Counsel NA
Ms. Sheri Smith Acting Head of Clinical Operations NA
Mr. Igor Gorbatchevsky M.D. Chief Medical Officer NA
Mr. Eldon C. Mayer III, M.B.A. Chief Commercial Officer 1961

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 31, 2026 Richard E Buller N/A Sale 3.00K $110.27 $330.81K
Jan 27, 2026 David Dalvey N/A Sale 20.00K $120.03 $2.40M
Dec 05, 2025 Richard E Buller N/A Sale 3.00K $105.69 $317.07K
Nov 20, 2025 Richard E Buller N/A Sale 3.90K $96.73 $377.25K
Jul 28, 2025 David Dalvey N/A Sale 9.33K $45.12 $420.74K
Jul 28, 2025 David Dalvey N/A Sale 100.00K $43.98 $4.40M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Baker Bros Advisors LP 7.92M Mar 31, 2026 16.23% $5.19 0.00%
venBio Select Advisor LLC 3.38M Mar 31, 2026 6.92% $3.79 8.48%
Perceptive Advisors LLC 3.13M Mar 31, 2026 6.41% $6.97 -1.04%
RTW INVESTMENTS, LLC 3.04M Mar 31, 2026 6.23% $3.45 452.50%
BlackRock Inc 2.71M Mar 31, 2026 5.56% $0.01 6.74%
NEA Management Company, LLC 2.29M Mar 31, 2026 4.69% $14.83 -35.36%
Vanguard Group Inc 2.28M Dec 31, 2025 4.67% $0.00 10.70%
Vanguard Capital Management, LLC 1.78M Mar 31, 2026 3.66% $0.01 0.00%
Deerfield Management Co 1.71M Mar 31, 2026 3.51% $2.31 0.00%
State Street Corp 1.52M Mar 31, 2026 3.11% $0.01 -7.27%
Morgan Stanley - Brokerage Accounts 1.35M Mar 31, 2026 2.76% $0.01 -3.81%
Soleus Capital Management, L.P. 1.28M Mar 31, 2026 2.63% $5.94 -28.97%
T. Rowe Price Associates, Inc. 1.28M Mar 31, 2026 2.62% $0.02 3.19%
TANG CAPITAL MANAGEMENT LLC 1.05M Mar 31, 2026 2.15% $6.09 0.00%
Geode Capital Management, LLC 891.07K Mar 31, 2026 1.83% $0.01 7.27%
The Toronto-Dominion Bank 882.76K Mar 31, 2026 1.81% $0.14 0.00%
The Goldman Sachs Group Inc 764.98K Mar 31, 2026 1.57% $0.01 17.18%
Bank of America Corp 714.33K Mar 31, 2026 1.46% $0.01 -26.89%
Apis Capital Advisors, LLC 515.00K Mar 31, 2026 1.06% $9.07 -14.45%
Nearwater Capital Markets, Ltd 473.10K Mar 31, 2026 0.97% $1.27 -9.05%

Shares Statistics

Shares Outstanding: 48.77M
Shares Float: 26.81M
% Insiders: 1,002.70%
% Institutions: 10,177.90%
Short % Float: 32.87%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.34M 2.75% ▲ 0.27% Apr 30, 2026
2 iShares Russell 2000 ETF 839.28K 1.72% ▲ 0.93% May 29, 2026
3 State Street® SPDR® S&P® Biotech ETF 810.09K 1.66% ▼ 0.61% May 31, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 407.72K 0.84% ▲ 1.03% Apr 30, 2026
5 T. Rowe Price Health Sciences 376.20K 0.77% ▼ 30.37% Apr 30, 2026
6 Fidelity Small Cap Index 343.96K 0.71% ▲ 9.24% Mar 31, 2026
7 T. Rowe Price New Horizons 308.74K 0.63% ▲ 25.47% Apr 30, 2026
8 Belfius Equities Cure C Cap 302.31K 0.62% ▼ 16.99% Nov 30, 2025
9 Artisan Non-U.S. Small-Mid Growth Comp 283.25K 0.58% ▼ 14.58% Mar 31, 2026
10 Artisan International Small-Mid Investor 283.25K 0.58% ▼ 14.58% Mar 31, 2026

Valuation Metrics

Enterprise Value: $5.47B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $5.54B
EBITDA: $-186.39M
Book Value: $1.11
Earnings/Share: $-3.90
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -37.12%
ROE (TTM): -275.17%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 10.55x 3.20x 0.78x -10.04x -2.02x
2024-12-31 7.71x 0.85x 0.53x -11.02x -0.97x
2023-12-31 13.43x 0.27x 0.27x -12.43x -0.64x
2022-12-31 25.45x 0.26x 0.24x -18.70x -0.92x
2021-12-31 34.06x 0.22x 0.20x -22.46x -0.53x
2020-12-31 10.26x 0.02x 0.10x -79,634.70x -0.02x
2019-12-31 21.12x 0.01x 0.05x -49,089.94x -0.02x
2018-12-31 38.07x 0.00x 0.03x -71,464.31x 0.00x
2017-12-31 42.36x 0.00x 0.02x -13.18x 0.00x
2016-12-31 13.27x 0.00x 0.07x N/A 0.00x
2015-12-31 18.06x 0.00x 0.05x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CELC.US!